“…Furthermore, the H 3 R was not detected in intestinal tissue (Sander et al, 2006). This data was further confirmed by Boer K et al, that also demonstrated a decreased of H 1 R and H 4 R protein levels in colorectal cancer while the levels of the H 2 R were not modified compared to normal colon mucosa (Boer et al, 2008). It was described that the H 1 R antagonist, loratadine, inhibited proliferation and enhanced radiosensitivity in human colon cancer cells (Soule et al, 2010).…”
Section: Histamine Receptors In Colorectal Cancersupporting
confidence: 71%
“…Furthermore, JNJ7777120 inhibited the cell growth induced by histamine in three different human colon cancer cell lines and also inhibited the histamine-mediated increase in VEGF in two cell lines. Combined treatment with zolantidine (an H 2 R antagonist) and JNJ7777120 determined an additive effect on reducing the histamine-induced VEGF production and histamine-stimulated proliferation , suggesting the involvement of H 4 R in colon carcinogenesis (Boer et al, 2008).…”
Section: Histamine Receptors In Colorectal Cancermentioning
“…Furthermore, the H 3 R was not detected in intestinal tissue (Sander et al, 2006). This data was further confirmed by Boer K et al, that also demonstrated a decreased of H 1 R and H 4 R protein levels in colorectal cancer while the levels of the H 2 R were not modified compared to normal colon mucosa (Boer et al, 2008). It was described that the H 1 R antagonist, loratadine, inhibited proliferation and enhanced radiosensitivity in human colon cancer cells (Soule et al, 2010).…”
Section: Histamine Receptors In Colorectal Cancersupporting
confidence: 71%
“…Furthermore, JNJ7777120 inhibited the cell growth induced by histamine in three different human colon cancer cell lines and also inhibited the histamine-mediated increase in VEGF in two cell lines. Combined treatment with zolantidine (an H 2 R antagonist) and JNJ7777120 determined an additive effect on reducing the histamine-induced VEGF production and histamine-stimulated proliferation , suggesting the involvement of H 4 R in colon carcinogenesis (Boer et al, 2008).…”
Section: Histamine Receptors In Colorectal Cancermentioning
“…1,5 H2 receptors have been documented in breast cancer cells and significantly altered populations of H1, H2, and H4 receptors have been detected in colorectal cancers. 66 Decreased expression of the H4 receptor has been noted in colorectal carcinoma. 67 H2 antagonism has been shown to decrease growth of some tumor cell lines.…”
“…74 Recent studies have evidenced the presence of H 4 Rs in gastric and colorectal tumor cells and a reduction of H 4 R density has been observed, which parallels the cancer progression. 54,55,56 However, functional data with histamine and H 4 R ligands are contradictory, with both stimulation and/or inhibition of cell proliferation and cell growth being observed.…”
mentioning
confidence: 99%
“…39,[55][56] Cell types expressing H 4 R include immune and inflammatory cells, epithelial cells and neurons of the myenteric and submucous plexus. Interestingly, H 4 R expression was found in ghrelin-producing cells of the rat stomach, 37 leading to speculation about a possible role of histamine in the secretion of the orexigenic peptide.…”
The functional role of histamine H 4 receptors (H 4 Rs) in the Gastrointestinal (GI) tract is reviewed, with particular reference to their involvement in the regulation of gastric mucosal defense and inflammation. H 4 Rs have been detected in different cell types of the gut, including immune cells, paracrine cells, endocrine cells and neurons, from different animal species and humans; moreover, H 4 R expression was reported to be altered in some pathological conditions, such as colitis and cancer. Functional studies have demonstrated protective effects of H 4 R antagonists in several experimental models of gastric mucosal damage and intestinal inflammation, suggesting a potential therapeutic role of drugs targeting this new receptor subtype in GI disorders, such as allergic enteropathy, Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS) and cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.